The DOI matches its Crossref record.
Cell Therapy Attenuates Deleterious Ventricular Remodeling and Improves Cardiac Performance After Myocardial Infarction
Abstract
Background —Myocardial infarction (MI) promotes deleterious remodeling of the myocardium, resulting in ventricular dilation and pump dysfunction. We examined whether supplementing infarcted myocardium with skeletal myoblasts would (1) result in viable myoblast implants, (2) attenuate deleterious remodeling, and (3) enhance in vivo and ex vivo contractile performance. Methods and Results —Experimental MI was induced by 1-hour coronary ligation followed by reperfusion in adult male Lewis rats. One week after MI, 10 6 myoblasts were injected directly into the infarct region. Three groups of animals were studied at 3 and 6 weeks after cell therapy: noninfarcted control (control), MI plus sham injection (MI), and MI plus cell injection (MI+cell). In vivo cardiac function was assessed by maximum exercise capacity testing and ex vivo function was determined by pressure-volume curves obtained from isolated, red cell–perfused, balloon–in–left ventricle (LV) hearts. MI and MI+cell hearts had indistinguishable infarct sizes of ≈30% of the LV. At 3 and 6 weeks after cell therapy, 92% (13 of 14) of MI+cell hearts showed evidence of myoblast graft survival. MI+cell hearts exhibited attenuation of global ventricular dilation and reduced septum–to–free wall diameter compared with MI hearts not receiving cell therapy. Furthermore, cell therapy improved both post-MI in vivo exercise capacity and ex vivo LV systolic pressures. Conclusions —Implanted skeletal myoblasts form viable grafts in infarcted myocardium, resulting in enhanced post-MI exercise capacity and contractile function and attenuated ventricular dilation. These data illustrate that syngeneic myoblast implantation after MI improves both in vivo and ex vivo indexes of global ventricular dysfunction and deleterious remodeling and suggests that cellular implantation may be beneficial after MI.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Human Mesenchymal Stem Cells Differentiate to a Cardiomyocyte Phenotype in the Adult Murine Heart
Toma, C., Pittenger, M. F., Cahill, K. S., Byrne, B. J., & Kessler, P. D. (2002) · Circulation · doi:10.1161/hc0102.101442 · Cited by 2,234
Laflamme, M. A., & Murry, C. E. (2005) · Nature Biotechnology · doi:10.1038/nbt1117 · Cited by 964
Smits, P. C., van Geuns, R.-J. M., Poldermans, D., Bountioukos, M., Onderwater, E. E. M., Lee, C. H., Maat, A. P. W. M., & Serruys, P. W. (2003) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2003.06.017 · Cited by 535
Stem-cell-based therapy and lessons from the heart
Passier, R., van Laake, L. W., & Mummery, C. L. (2008) · Nature · doi:10.1038/nature07040 · Cited by 525
Autologous skeletal myoblasts transplanted to ischemia-damaged myocardium in humans
Pagani, F. D., DerSimonian, H., Zawadzka, A., Wetzel, K., Edge, A. S. B., Jacoby, D. B., Dinsmore, J. H., Wright, S., Aretz, T. H., Eisen, H. J., et al. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00081-0 · Cited by 481
Self-citation
Metadata
- Authors
- Jain, M., DerSimonian, H., Brenner, D. A., Ngoy, S., Teller, P., Edge, A. S. B., Zawadzka, A., Wetzel, K., Sawyer, D. B., Colucci, W. S., Apstein, C. S., & Liao, R.
- Venue
- Circulation
- Published
- 2001-04-10
- Volume
- 103
- Issue
- 14
- Pages
- 1920-1927
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2028163205
- Cited by
- 294
- References
- 0
- FWCI
- 20.63
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cell Therapy Attenuates Deleterious Ventricular Remodeling and Improves Cardiac Performance After Myocardial Infarction. https://app.cochat.ai/papers/10.1161/01.cir.103.14.1920
- The paper
- Jain, M., DerSimonian, H., Brenner, D. A., Ngoy, S., Teller, P., Edge, A. S. B., Zawadzka, A., Wetzel, K., Sawyer, D. B., Colucci, W. S., Apstein, C. S., & Liao, R. (2001). Cell Therapy Attenuates Deleterious Ventricular Remodeling and Improves Cardiac Performance After Myocardial Infarction. Circulation. https://doi.org/10.1161/01.cir.103.14.1920
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.